A randomized , double-blind, placebo-controlled study of antidepressant effects of the endogen compound neuropeptide y (NPY) in patients suffering from major depressive disorder
This historical record does not confirm current site availability.
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Sweden
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
This is historical registry information. What is the current study status and protocol?
Things to check before joining
- Recruitment status
- Terminated
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Karolinska University Hospital, Huddinge
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Sweden
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2014-000129-19
- Official title
Show the full official title
A randomized , double-blind, placebo-controlled study of antidepressant effects of the endogen compound neuropeptide y (NPY) in patients suffering from major depressive disorder
Recruitment & locations
Sweden
Registry details
- Sweden — Prematurely Ended
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Karolinska University Hospital, Huddinge, a hospital or academic medical center.
Is this study still recruiting?
The historical registry lists this study as terminated.
